Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus

Neuronal lesions have been considered the hallmark of chagasic megaesophagus, but the role of Trypanosoma cruzi and the participation of the inflammatory cells in this process are still debated. In the present study we counted neurons in the oesophagus from patients with and without megaesophagus and further examined these samples for the presence of parasite kDNA and cells with cytolytic potential (Natural Killer cells, cytotoxic lymphocytes and macrophages). The presence of parasite kDNA was demonstrated in 100% of cases with megaesophagus and in 60% of patients without megaesophagus. When analysed for the number of neurons, the patients without megaesophagus could be classified into 2 groups, as having normal or a decreased number of neurons. The former group did not show any inflammatory process, but interestingly, all patients without megaesophagus presenting decreased number of neurons also presented both parasite kDNA and inflammatory process in the organ. We further observed that the numbers of cytotoxic cells in the myenteric plexus region inversely correlate with the number of neurons. These data together strongly suggest that chronic lesions in chagasic megaesophagus might be a consequence of immune-mediated mechanisms, that last until the chronic phase of infection, and are dependent on the persistence of parasite in the host's tissue.

[1]  P. Gutierrez,et al.  Acute Chagas’ disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. , 2005, Acta cardiologica.

[2]  J. Hoebeke,et al.  Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2β protein in patients with chronic Chagas’ heart disease , 2004, Clinical and experimental immunology.

[3]  C. Carneiro,et al.  Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. , 2004, The Journal of antimicrobial chemotherapy.

[4]  L. Smith,et al.  Transfusion–Transmitted Parasites , 2003, American Society for Clinical Laboratory Science.

[5]  J. Altcheh,et al.  Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. , 2003, The Journal of antimicrobial chemotherapy.

[6]  B. Fleischer,et al.  Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice. , 2003, Microbes and infection.

[7]  F. Kierszenbaum Views on the autoimmunity hypothesis for Chagas disease pathogenesis. , 2003, FEMS immunology and medical microbiology.

[8]  R. Corrêa-Oliveira,et al.  Chronic Chagas disease: presence of parasite DNA in the oesophagus of patients without megaoesophagus. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  D. Hoft,et al.  Type 1 Immunity Provides Optimal Protection against Both Mucosal and Systemic Trypanosoma cruzi Challenges , 2002, Infection and Immunity.

[10]  R. Ribeiro‐dos‐Santos,et al.  Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. , 2002, Journal of autoimmunity.

[11]  S. D. Pena,et al.  Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism. , 2001, The American journal of tropical medicine and hygiene.

[12]  A Prata,et al.  Clinical and epidemiological aspects of Chagas disease. , 2001, The Lancet. Infectious diseases.

[13]  J. Gama-Rodrigues,et al.  Cell-mediated immune response in megacolon from patients with chronic chagas' disease , 2001, Diseases of the colon and rectum.

[14]  R. Corrêa-Oliveira,et al.  Phenotypic characterization of the inflammatory cells in chagasic megaoesophagus. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  J. Kalil,et al.  Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last? , 1996, Parasitology today.

[16]  R. Corrêa-Oliveira,et al.  PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease , 1996, The Lancet.

[17]  R. McGraw,et al.  Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets. , 1995, Journal of immunological methods.

[18]  E. Jones,et al.  Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. , 1993, The American journal of tropical medicine and hygiene.

[19]  E. R. Lopes,et al.  Contribuição ao estudo da anatomia patológica do megaesôfago chagásico , 1991 .

[20]  H. Waskin,et al.  Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California , 1991, Transfusion.

[21]  M. V. Regenmortel,et al.  Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease , 1991, Clinical and experimental immunology.

[22]  W. Degrave,et al.  Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease. , 1989, Molecular and biochemical parasitology.

[23]  T. Navin,et al.  Human and sylvatic Trypanosoma cruzi infection in California. , 1985, American journal of public health.

[24]  A. Szarfman,et al.  Chagasic Cardiopathy: Demonstration of a Serum Gamma Globulin Factor Which Reacts with Endocardium and Vascular Structures , 1974, Circulation.

[25]  A. deOliveira,et al.  Clinical and radiological aspects of aperistalsis of the esophagus , 1960 .

[26]  J. Hoebeke,et al.  Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease. , 2004, Clinical and experimental immunology.

[27]  R. Melo,et al.  Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. , 2001, Experimental parasitology.

[28]  E. Chapadeiro Clinical evolution and morbi-mortality in Chagas disease. , 1999, Memorias do Instituto Oswaldo Cruz.

[29]  S. D. Pena,et al.  Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. , 1998, Experimental parasitology.

[30]  R. Dantas,et al.  Gastrointestinal manifestations of chagas' disease , 1998, American Journal of Gastroenterology.

[31]  F. Köberle Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. , 1968, Advances in parasitology.